Stockscreener 앱 받기
16.11
2.33%
-0.385
전일 마감가:
$16.50
열려 있는:
$16.72
하루 거래량:
559.94K
Relative Volume:
0.69
시가총액:
$1.36B
수익:
$17.49M
순이익/손실:
$-78.50M
주가수익비율:
-13.43
EPS:
-1.2
순현금흐름:
$-52.85M
1주 성능:
-0.52%
1개월 성능:
+18.32%
6개월 성능:
+61.47%
1년 성능:
+13.05%
1일 변동 폭
$16.10
$16.74
1주일 범위
$16.10
$16.81
52주 변동 폭
$8.26
$16.99
Liquidia Corp Stock (LQDA) Company Profile
명칭
Liquidia Corp
전화
919.328.4400
주소
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
LQDA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LQDA
Liquidia Corp
|
16.11 | 1.36B | 17.49M | -78.50M | -52.85M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-20 | 개시 | Wells Fargo | Overweight |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-08-19 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-08-16 | 개시 | Raymond James | Outperform |
| 2024-06-25 | 개시 | Oppenheimer | Perform |
| 2024-01-05 | 재확인 | Needham | Buy |
| 2022-09-19 | 재개 | Wedbush | Underperform |
| 2022-09-01 | 다운그레이드 | Wedbush | Neutral → Underperform |
| 2022-07-22 | 개시 | Ladenburg Thalmann | Buy |
| 2022-05-31 | 개시 | BTIG Research | Buy |
| 2022-05-26 | 개시 | BofA Securities | Buy |
| 2020-12-04 | 개시 | H.C. Wainwright | Buy |
| 2020-11-20 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2018-11-08 | 재개 | Jefferies | Buy |
| 2018-09-05 | 개시 | Wedbush | Outperform |
| 2018-08-20 | 개시 | Jefferies | Buy |
| 2018-08-20 | 개시 | Needham | Buy |
모두보기
Liquidia Corp 주식(LQDA)의 최신 뉴스
Bleakley Financial Group LLC Lowers Stock Position in Liquidia Co. (NASDAQ:LQDA) - Defense World
The Attractiveness of Investing In Liquidia Corp (LQDA) is Growing - Knox Daily
Liquidia Co. (NASDAQ:LQDA) Receives $25.38 Average Price Target from Brokerages - MarketBeat
Liquidia Corp's chief business officer sells $6,319 in stock - MSN
Life Sciences Group Of The Year: Cooley - Law360
Stock Performance Spotlight: Liquidia Corp (LQDA) Ends the Day at 15.74, Up by 3.89 - The Dwinnex
Liquidia Corp.: We Have Exposure To The Upside Now - Seeking Alpha
Liquidia Corp (LQDA) stock on the rise: An overview - US Post News
This trade activity should not be overlooked: Liquidia Corp (LQDA) - SETE News
Liquidia Corp [LQDA] Investment Appeal on the Rise - Knox Daily
Liquidia Corporation's Long-Running Saga Is Coming To An End (NASDAQ:LQDA) - Seeking Alpha
Liquidia Corp's chief medical officer sells $31,785 in stock - MSN
Liquidia Co. (NASDAQ:LQDA) Insider Sells $31,785.00 in Stock - MarketBeat
Liquidia Corp's chief medical officer sells $31,785 in stock By Investing.com - Investing.com UK
Liquidia Technologies (LQDA) Moves 5.7% Higher: Will This Strength Last? - Yahoo Finance
Barclays PLC Purchases 72,591 Shares of Liquidia Co. (NASDAQ:LQDA) - Defense World
Liquidia Corp CFO Michael Kaseta sells shares worth $275,298 By Investing.com - Investing.com Australia
Rajeev Saggar Sells 6,249 Shares of Liquidia Co. (NASDAQ:LQDA) Stock - MarketBeat
Roger Jeffs Sells 22,343 Shares of Liquidia Co. (NASDAQ:LQDA) Stock - MarketBeat
Liquidia Co. (NASDAQ:LQDA) General Counsel Russell Schundler Sells 16,393 Shares - MarketBeat
Liquidia's chief medical officer Rajeev Saggar sells $73,613 in stock By Investing.com - Investing.com Australia
Liquidia's chief commercial officer sells shares worth $98,504 By Investing.com - Investing.com Australia
Liquidia’s chief commercial officer sells shares worth $98,504 By Investing.com - Investing.com Nigeria
Liquidia Corp chief business officer sells $56,650 in stock By Investing.com - Investing.com South Africa
Liquidia's chief commercial officer sells shares worth $98,504 - Investing.com India
Liquidia's chief medical officer Rajeev Saggar sells $73,613 in stock - Investing.com India
Liquidia Corp general counsel sells shares worth $193,109 - Investing.com India
Liquidia Corp chief business officer sells $56,650 in stock - Investing.com
Liquidia Corp CFO Michael Kaseta sells shares worth $275,298 - Investing.com
Liquidia Corp general counsel sells shares worth $193,109 By Investing.com - Investing.com UK
Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight - GlobeNewswire Inc.
Liquidia’s (LQDA) Buy Rating Reiterated at Needham & Company LLC - Defense World
Analysts Set Liquidia Co. (NASDAQ:LQDA) Price Target at $25.38 - MarketBeat
Liquidia's (LQDA) "Buy" Rating Reaffirmed at Needham & Company LLC - MarketBeat
Breaking Down Liquidia: 4 Analysts Share Their Views - Benzinga
Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference - Yahoo Finance
Liquidia CEO to Present at J.P. Morgan Healthcare Conference 2025 in San Francisco - StockTitan
Yutrepia's Launch: A Catalyst for Liquidia (LQDA) - substack.com
Liquidia Co. (NASDAQ:LQDA) Shares Sold by Geode Capital Management LLC - MarketBeat
Barclays PLC Buys 72,591 Shares of Liquidia Co. (NASDAQ:LQDA) - MarketBeat
Barclays PLC Boosts Stock Position in Liquidia Co. (NASDAQ:LQDA) - Defense World
Jim Cramer’s Hidden Gem: Why Liquidia Corporation (LQDA) Is the Undervalued Stock You Need to Know - Insider Monkey
State Street Corp Decreases Stock Holdings in Liquidia Co. (NASDAQ:LQDA) - Defense World
State Street Corp Has $21.75 Million Holdings in Liquidia Co. (NASDAQ:LQDA) - MarketBeat
Liquidia (NASDAQ:LQDA) Research Coverage Started at Wells Fargo & Company - Defense World
Wells Fargo & Company Initiates Coverage on Liquidia (NASDAQ:LQDA) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $833,000 Stake in Liquidia Co. (NASDAQ:LQDA) - Defense World
Liquidia Corp (LQDA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Liquidia Corp 주식 (LQDA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Saggar Rajeev | Chief Medical Officer |
Jan 21 '25 |
Sale |
13.00 |
2,445 |
31,785 |
267,943 |
| Schundler Russell | General Counsel |
Jan 14 '25 |
Sale |
11.78 |
16,393 |
193,110 |
573,478 |
| Saggar Rajeev | Chief Medical Officer |
Jan 14 '25 |
Sale |
11.78 |
6,249 |
73,613 |
270,388 |
| Moomaw Scott | Chief Commercial Officer |
Jan 14 '25 |
Sale |
11.78 |
8,362 |
98,504 |
215,494 |
| Kaseta Michael | CFO and COO |
Jan 14 '25 |
Sale |
11.78 |
23,370 |
275,299 |
401,755 |
| Adair Jason | Chief Business Officer |
Jan 14 '25 |
Sale |
11.78 |
4,809 |
56,650 |
180,215 |
| JEFFS ROGER | Chief Executive Officer |
Jan 14 '25 |
Sale |
11.78 |
22,343 |
263,201 |
1,019,177 |
| Moomaw Scott | Chief Commercial Officer |
Dec 02 '24 |
Sale |
11.51 |
546 |
6,284 |
154,127 |
| Kaseta Michael | CFO and COO |
Dec 02 '24 |
Sale |
11.51 |
1,091 |
12,557 |
312,328 |
| Schundler Russell | General Counsel |
Dec 02 '24 |
Sale |
11.51 |
1,063 |
12,235 |
487,328 |
0.27%
3.05%
자본화:
|
볼륨(24시간):